Oncology & Cancer

Immunotherapy to shrink treatment-resistant cancer tumors

Advancements in cancer research and treatment have resulted in great improvements in survival rates—today, there are almost 17 million people in the United States alone who have survived their diagnosis because of the physicians ...

Oncology & Cancer

Cancer: The double advantage of killer T-cells

To grow, tumors rely on a specific structure, the tumor stroma. This includes blood vessels, which provide the nutrients necessary for the multiplication of diseased cells, and of lymphatic vessels, through which they migrate ...

Oncology & Cancer

Researchers find new mechanism to turn on cancer-killing T cells

Over the past decade, researchers have made great strides in the development and administration of cancer immunotherapies, which use the body's own immune system to treat disease. However, the therapies don't work for every ...

Oncology & Cancer

T-cell interactions vary between tumor microenvironments

A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within the microenvironment of different regions of both brain tumors and brain metastases, according ...

Immunology

Discovery of central signaling pathway in immune cells

Autoimmune diseases are triggered when the immune system malfunctions and attacks the body's own structures. Although there is not, as yet, any cure for such diseases, their progression can be slowed down by therapeutic measures. ...

Immunology

Cannibal immune cells could offer new treatment path

Melbourne researchers have discovered that an immune cell, thought largely to be focused on fighting infection in newborns and infants, can in fact cannibalize the features of other immune cells, making it a potential new ...

page 8 from 40